AveXis (AVXS) Reports Q3 Loss of $0.87/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UPDATE: Stifel Starts AveXis (AVXS) at Hold
November 14, 2016 7:33 AM EST(Updated - November 14, 2016 9:08 AM EST)
Stifel initiated coverage on AveXis (NASDAQ: AVXS) with a Hold rating and a price target of $65.
Analyst Katherine Breedis said, "We believe AVXS has strong management as well as an exciting gene therapy asset, Ph.I AVXS-101, which has... More
